According to a recent release from GlobalData, Eli Lilly’s obesity offering could become a potential leader in the market.

Discover a study where findings demonstrate that hypovolaemic phlebotomy effectively reduces the need for red blood cell ...

A recent Phase 1 clinical trial has provided promising results for a novel immunotherapy approach to treat early-stage ...

A recent study shows influenza vaccination provides consistent protection for children against all levels of severe flu ...

Enhanced glucose processing during oral glucose tolerance testing significantly improves the accuracy and equity of ...

A recent study has introduced FlowScore, a new metric for evaluating the quality of red blood cells that goes beyond ...

Avacopan treatment for vasculitis patients shows a significant risk of liver injury, especially in older and low-weight ...

Novartis’ Phase III study has demonstrated significant improvement in motor function in children and young adults with spinal ...

AAS use linked to persistent coronary dysfunction, even years post-cessation, stressing long-term cardiovascular concerns.

Welcome to a new edition of Spoonful of Technology, where we look at how technology can solve key pharma industry challenges.

Discover a study where results suggest that patients with cutaneous lupus erythematosus may benefit from increased vigilance ...

A recent study examining the effectiveness of a telemedicine-based exercise programme for cancer survivors has shown ...